Scout Investments, Inc. Novo Cure LTD Transaction History

Scout Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 14, 2022	SELL	$75.08 - $121.99 $2.17 Million - $3.52 Million	-28,890 Closed	0 $0
Q3 2021 Oct 13, 2021	SELL	$116.17 - $194.55 $2.76 Million - $4.62 Million	-23,748 Reduced 45.12%	28,890 $3.36 Million
Q2 2021 Jul 23, 2021	SELL	$130.4 - $225.58 $3.21 Million - $5.55 Million	-24,588 Reduced 31.84%	52,638 $11.7 Million
Q1 2021 Apr 09, 2021	SELL	$124.11 - $190.17 $3.06 Million - $4.69 Million	-24,636 Reduced 24.19%	77,226 $10.2 Million
Q4 2020 Jan 12, 2021	SELL	$112.16 - $174.14 $114,066 - $177,100	-1,017 Reduced 0.99%	101,862 $17.6 Million
Q3 2020 Oct 13, 2020	BUY	$58.05 - $111.31 $5.97 Million - $11.5 Million	102,879 New	102,879 $11.5 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.69B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Scout Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Scout Investments, Inc. with notifications on news.